{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:30:08Z","timestamp":1777887008954,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","award":["AWAKE-HF NCT02970669"],"award-info":[{"award-number":["AWAKE-HF NCT02970669"]}],"id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003359","name":"Scoliosis Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cardfail.2021.07.021","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T10:51:05Z","timestamp":1629543065000},"page":"1466-1471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Sleep Outcomes From AWAKE-HF: A Randomized Clinical Trial of Sacubitril\/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6515-6204","authenticated-orcid":false,"given":"ROBERT L.","family":"Owens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KADE","family":"BIRKELAND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. THOMAS","family":"HEYWOOD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEVEN R.","family":"STEINHUBL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JONAS","family":"DORN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DANIEL","family":"GRANT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EMMANUEL","family":"FOMBU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RAJ","family":"KHANDWALLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2021.07.021_bib0001","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1001\/jama.2008.867","article-title":"Short sleep duration and incident coronary artery calcification","volume":"300","author":"King","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0002","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archinte.163.2.205","article-title":"A prospective study of sleep duration and coronary heart disease in women","volume":"163","author":"Ayas","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0003","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/01.HYP.0000217362.34748.e0","article-title":"Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey","volume":"47","author":"Gangwisch","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2019.01.033","article-title":"Association of short sleep duration and atrial fibrillation","author":"Genuardi","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0005","first-page":"252","article-title":"Characteristics of sleep in patients with stable heart failure versus a comparison group","volume":"35","author":"Redeker","year":"2006","journal-title":"J Crit Care"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0006","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrcardio.2016.71","article-title":"Heart failure and sleep disorders","volume":"13","author":"Parati","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0007","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pcad.2008.02.001","article-title":"Sleep in heart failure","volume":"51","author":"Naughton","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0008","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jacc.2006.12.046","article-title":"Influence of obstructive sleep apnea on mortality in patients with heart failure","volume":"49","author":"Wang","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0009","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/eurheartj\/ehu522","article-title":"Sleep disordered breathing and post-discharge mortality in patients with acute heart failure","volume":"36","author":"Khayat","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0010","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.111.070813","article-title":"Sleep apnea and cardiovascular disease: a bidirectional relationship","volume":"126","author":"Kasai","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0011","unstructured":"Novartis Pharmaceuticals Corporation. ENTRESTO\u00ae (sacubitril and valsartan) tablets, for oral use. East Hanover, NJ: Novartis Pharmaceutical Corporation; 11\/2018."},{"key":"10.1016\/j.cardfail.2021.07.021_bib0012","first-page":"125","article-title":"Sacubitril\/valsartan improves left ventricular ejection fraction and reverses cardiac remodeling in taiwanese patients with heart failure and reduced ejection fraction","volume":"36","author":"Liu","year":"2020","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0013","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cardfail.2013.04.005","article-title":"Sleep-disordered breathing in heart failure: identifying and treating an important but often unrecognized comorbidity in heart failure patients","volume":"19","author":"Khayat","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0014","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000455118","article-title":"Resolution of Cheyne-Stokes Respiration after Treatment of Heart Failure with Sacubitril\/Valsartan: A First Case Report","volume":"137","author":"Fox","year":"2017","journal-title":"Cardiology"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0015","article-title":"AWAKE-HF","volume":"31","author":"Khandwalla","year":"2019","journal-title":"Rationale and design of a study using continuous-wear activity sensors to objectively evaluate the effect of initiation of sacubitril\/valsartan on physical activity, symptoms, and sleep in ambulatory participants with heart failure"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0016","article-title":"The AWAKE-HF Study: sacubitril\/valsartan impact on daily physical activity and sleep in heart failure","author":"Khandwalla","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0017","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jchf.2015.09.014","article-title":"Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF Registry","volume":"4","author":"Arzt","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0018","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejheart.2006.08.003","article-title":"Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients","volume":"9","author":"Oldenburg","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0019","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijcard.2021.02.012","article-title":"Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction","volume":"330","author":"Passino","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1164\/rccm.201003-0406OC","article-title":"Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure","volume":"183","author":"Javaheri","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0021","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.5664\/jcsm.4096","article-title":"Diagnosis and treatment of sleep disordered breathing in hospitalized cardiac patients: a reduction in 30-day hospital readmission rates","volume":"10","author":"Kauta","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0022","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.5664\/jcsm.6344","article-title":"Adherence to positive airway pressure therapy in hospitalized patients with decompensated heart failure and sleep-disordered breathing","volume":"12","author":"Sharma","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0023","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022479","article-title":"Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea","volume":"348","author":"Kaneko","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0024","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1001\/archinte.166.16.1716","article-title":"Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea","volume":"166","author":"Arzt","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0025","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1183\/09031936.06.00063005","article-title":"Symptom burden of sleep-disordered breathing in mild-to-moderate congestive heart failure patients","volume":"27","author":"Hastings","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0026","doi-asserted-by":"crossref","first-page":"e12717","DOI":"10.1111\/jsr.12717","article-title":"Discrepancy between wrist-actigraph and polysomnographic measures of sleep in patients with stable heart failure and a novel approach to evaluating discrepancy","volume":"28","author":"Jeon","year":"2019","journal-title":"J Sleep Res"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0027","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjcard.2020.04.012","article-title":"Sleep duration and cardiovascular health in a representative community population (from NHANES, 2005 to 2016)","volume":"127","author":"Krittanawong","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0028","article-title":"Use of actigraphy (wearable digital sensors to monitor activity) in heart failure randomized clinical trials: a scoping review","author":"Anchouche","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0029","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIRCULATIONAHA.119.040798","article-title":"Technology-Enabled clinical trials: transforming medical evidence generation","volume":"140","author":"Marquis-Gravel","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.07.021_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.chest.2018.04.008","article-title":"Portable sleep monitoring for diagnosing sleep apnea in hospitalized patients with heart failure","volume":"154","author":"Aurora","year":"2018","journal-title":"Chest"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916421003407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916421003407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:57:54Z","timestamp":1777607874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916421003407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1071916421003407"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.07.021","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sleep Outcomes From AWAKE-HF: A Randomized Clinical Trial of Sacubitril\/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}